Impact of Vitamin D on Diabetic Kidney Disease in African Americans
Public ClinicalTrials.gov record NCT01214356. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This purpose of this project is to evaluate the effectiveness of vitamin D supplementation over 12 months in vitamin D deficient African American adults with type 2 diabetes.
Study identification
- NCT ID
- NCT01214356
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 54 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 31, 2010
- Primary completion
- Jun 30, 2013
- Completion
- Jun 30, 2013
- Last update posted
- Oct 15, 2018
2010 – 2013
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Medical University of South Carolina | Charleston | South Carolina | 29425 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Recently updated Diabetic Kidney Disease trials
Other public records listing Diabetic Kidney Disease. Sorted by last update posted; newest first. Not a recommendation.
- NCT04791358: Decision Impact Trial of KidneyIntelX Active, not recruiting
- NCT05822609: Trial of Semaglutide for Diabetic Kidney Disease in Type 1 Diabetes Recruiting
- NCT05507892: Renal Mechanism of SGLT2 Inhibition Active, not recruiting
- NCT00342927: Family Investigation of Nephropathy and Diabetes (F.I.N.D.) Active, not recruiting
- NCT05759468: NAD Augmentation in Diabetes Kidney Disease Recruiting
- NCT03625648: Pentoxifylline in Diabetic Kidney Disease Active, not recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01214356, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 15, 2018 · Synced Sep 1, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01214356 live on ClinicalTrials.gov.